Email

Ce: "Glass, Roger (NIH/FIC) [E]" <{{@mail.nih.gov>, "Kilmarx, Peter (NIH/FIC) [E]" @nih.gov>, "Wolinetz, Carrie (NIH/OD) [E]" <i Onih.gov>, "Lauer, Michael (NIH/OD) [E]" <{EE@nih.gov>, "Garbarini, Nicole (NIH/OD) (E]" @nih.gov>, "Johnson, Martin S. (NIH/NIAID) [E]" @niaid.nih.gov>, "McGowan, John J. (NIH/NIAID) [E]" @niaid.nih.gov>, "Schwetz, Tara (NIH/NIAID) [E]" <Onih. gov> Subject: RE: Need info on BMGF -- Urgent Date: Fri, 25 May 2018 21:05:32 -0400 Importance: Normal Attachments: Select_Recent_Highlights.docx Hi Larry, In reviewing the spreadsheet and links, here are two additions: « As Francis notes, NCI and the Gates Foundation are cost-sharing an HPV vaccine post licensure trial to find out if giving only one dose of either the Cervarix or Gardasil 9 vaccines work the same as giving two doses of these vaccines to young women - The ESCUDDO Study. The Gates Foundation commitment is $20 million. + NIH and the Gates Foundation also are co-supporting an African Post-Doctoral Training Initiative (APTI) within the intramural program. The Gates Foundation commitment over six years is $2 million. The NIH commitment over that timeframe is $2.2 million I'm unsure if the attached document would be useful to you, given the nature of the request, but if so, attached is a sampling of recent highlights/developments in the NIH-Gates cooperation, including the HIV vaccine cooperation